Cartiva implantation vs. MTP-I arthrodesis - retrospective analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021476

Enrollment

Registered

2020-06-08

Start date

2020-01-17

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M20.2 Z98.1

Interventions

Group 1: Patients who have already been treated with Cartiva are invited to a clinical follow-up. A clinical examination is carried out according to the orthopedic routine with a differentiated clinic

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: • Cartiva® implantation MTP-I joint • female and male patients • Age 18 to 80 years

Exclusion criteria

Exclusion criteria: • no

Design outcomes

Primary

Measure	Time frame
The primary goal of the planned study is to evaluate the outcome based on the results of a Cartiva® implantation in comparison with a matched-pair patient population after MTP-I arthrodesis.	—

Secondary

Measure	Time frame
The secondary goal is the descriptive presentation of the data for satisfaction and function (collected via scores) one year postoperatively.	—

Countries

Germany

Contacts

Public ContactYvonne Noll

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift, Leitung Klinisches Studienmanagement

yvonne.noll@diakovere.de0511-5354-649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026